Substituted cyclohexanones

Details Substituted cyclohexanones Substituted cyclohexanones

2008-04-25

2009-12-29

Davis, Brian J (Department: 1621)

Organic compounds -- part of the class 532-570 series

Organic compounds

Amino nitrogen containing

C514S647000

Reexamination Certificate

active

07638651

ABSTRACT:
Disclosed herein are substituted cyclohexanone-based NMDA receptor modulators of Formula I, process of preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.

REFERENCES:
patent: 7273889 (2007-09-01), Mermelstein et al.
patent: 2002/0013372 (2002-01-01), Ekins
patent: 2008/0033011 (2008-02-01), Tung
patent: 199526325 (1995-10-01), None
patent: 2008134525 (2008-11-01), None
The Merck Index 13thed., O'Neil senior editor, Merck & Co., Inc., Whitehouse Station NJ, p. 947, entry 5312.
Braga et al., Chem. Commun. (2005), 29. p. 3635-3645.
Burger's Medicinal Chemistry and Drug Discovery 5thed., vol. I, (1995), Manfred E. Wolff ed., John Wiley & Sons, NY, p. 975-977.
Modern Pharmaceutics 3rd ed., (1996), Gilbert S. Banker et al. ed., Marcel Dekker, Inc., p. 596.
The Merck Index 13thed., (2001), O'Neil senior editor, Merck & Co., Inc., Whitehouse Station NJ, p. 947, entry 5312.
Bauer, La et al; Influence of long-term infusions on lidocaine kinetics; Clin. Pharmacol. Ther. 1982, 433-7.
Borgstrom, L et al; Comparative Pharmacokinetics of Unlabeled and Deuterium-Labeled Terbutaline: Demonstration of a Small Isotope Effect; J Pharm Sci, 1988, 77(11), 952-4.
Browne, T.R.; Chapter 2. Isotope Effect: Implications for Pharmaceutical Investigations; Pharm—Lib—1997—13.
Browne, T.R. et al; Pharmacokinetic Equivalence of Stable-Isotope-Labeled and Unlabeled Drugs. Phenobarbital in Man; J Clin Pharmacol, 1982, 22, 309-315.
Burm, Agl et al; Pharmacokinetics of Lidocaine and bupivacaine and stable isotope-labeled analogs: a study in healthy volunteers; Biopharmaceutics and Drug Disposition, 1988, 9, 85-95.
Elison, C. et al; Effect of Deuteration of N-CH$—{3}$ Group on Potency and Enzymatic N-Demethylation of Morphine; Science, 1961, 134(3485), 1078-9.
Farmer, PB. et al.; Synthesis, Metabolism, and Antitumor Activity of Deuterated Analogues of 1-(2-Choloroethyl)-3-cyclohexyl-1-nitrosourea; Journal of Medicinal Chemistry, 1978, vol. 21, No. 6, 514-20.
Fisher, MB et al; The complexities inherent in attempts to decrease drug clearance by blocking sites of CYP-mediated metabolism; Curr Opin Drug Discov Develop; 2006, 9(1), 101-9.
Foster, AB; Deuterium Isotope Effects in Studies of Drug Metabolism; Trends in Pharmacological Sciences, Dec. 1984, 524-7.
Helfenbein, J, et al; Isotopic Effect Study of Propofol Deuteration on the Metabolism, Activity, and Toxicity of the Anesthetic; J. Med. Chem. 2002, 45, 5806-5808.
Kushner, DJ, et al; Pharmacological uses and perspectives of heavy water and deuterated compounds; Can J Phys Pharm 1999, 77, 79-88.
Lee, H., et al; Deuterium Magic Angle Spinning Studies of Substrates Bound to Cytochrome P450; Biochemistry 1999, 38, 10808-10813.
Mamada, K et al; Pharmacokinetic Equivalence of Deuterium-Labeled and Unlabeled Phenytoin; Drug Metabolism and Disposition, 1986, 14(4), 509-11.
Nelson, SD et al; The Use of Deuterium Isotope Effect to Probe the Active Site Properties, Mechanism of Cytochrome P450-catalyzed Reactions, and Mechanisms of Metabolically Dependent Toxicity; Drug Metabolism and Disposition 31:1481-1498, 2003.
Nelson, SD et al; Primary and B-Secondary Deuterium Isotope Effects in N-Deethylation Reactionsl; Journal of Medicinal Chemistry, 1975, vol. 18, No. 11.
Pohl, LR et al; Determination of toxic Pathways and Metabolism by Deuterium Substitution; Drug—Metabolism—Rev—1985—1335.
Rampe, D et al; Deuterated Analogs of verapamil and nifedipine. Synthesis and biological activity; Eur J Med Chem (1993) 28,259-263.
Leung, Ly et al.; Studies on the Biotransformation of Ketemine II—Quantitative Significance of the N-Demythylation Pathway in Rats in vivo Determined by a Novel Stable Isotope Technique; Biomedical and Environmental Mass Spectrometry, 1989, vol. 18, 401-4.
Shiue, C-Y et al; Carbon-11 Labeled Ketamine—Synthesis, Distribution in Mice and PET Studies in Baboons; Nuclear Medicine and Biology, 1997, vol. 24, 145-150.
Huang, M-K et al; Quantitative Detection of Ketamine, Norketamine, and Dehydronorketamine in Urine Using Chemical Derivatization Followed by Gas Chromatography—Mass Spectrometry; Journal of Chromatography B, 2005, 820, 165-73.
Trevor, AJ et al; Stereoselective metabolism of ketamine enantiomers; Scifinder Summary: Phencyclidine related arylcylohexylamines: present future appl. Proc. Jt Fr.—US Semin. Chem., Pharmacol., present future ther. appl. Drug Abuse Aspects Arylcyclohexylamines, 1983, Meeting Date 1982, 279-89.
Hartvig, P et al; Central nervous system effects of subdissociative doses of (S)-ketamine are related to plasma and brain concentrations measured with positron emission tomography in healthy volunteers; Clinical Pharmacology and Therapeutics, 1995, 58(2), 165-73.
Kratzsch, C et al; Simple APCI-LC-MS method for screening library-assisted identification and validated quantification of anesthetics, benzodiazepines and low-dosed opioids in plasma often asked for in the context of the diagnosis of brain death; GTFCh-Symposium: Ausgewaehlte Aspekte der Forensischen Toxikologie, Beitraege zum Symposium der Gesellschaft fuer Toxikologische und Forensische Chemie, 13th, Mosbach, Germany, Apr. 3-5, 2003 (2004), Meeting Date 2003, 299-309.
Stanaszek, R et al; Determination of trazodone and its metabolite 1-(3-chlorophenyl) piperazine (mCPP) in hair by the high performance liquid chromatography method coupled with mass spectrometry (HPLC-ESI-MS); Z Zagadnien Nauk Sadowych (2006), 66 131-139.
Brown, Stacy D. et al; A validated SPME-GC-MS method for simultaneous quantification of club drugs in human urine; Forensic science international (2007), 171(2-3), 142-50.
Trevor, AJ et al; Stereoselective metabolism of ketamine enantiomers; Phencyclidine related arylcyclohexylamines: present future appl. Proc. Jt Fr.—US Semin. Chem., Pharmacol., present future ther. appl. Drug Abuse Aspects Arylcyclohexylamines, 1983, Meeting Date 1982, 279-89.

Affiliated with

Also associated with

Rating

Substituted cyclohexanones does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted cyclohexanones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted cyclohexanones will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4145404